Skip to content

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-512528-13-00
Acronym
262SP101(ION464-CS1)
Enrollment
65
Registered
2024-08-14
Start date
2020-05-27
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple System Atrophy

Interventions

None listed

Sponsors

Ionis Pharmaceuticals Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Austria, France, Germany, Portugal

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026